Amongst the 77 participants included in the trial, there were no significant attenuation of skeletal mass loss with the addition of resistance training while the overall weight loss among both groups were statistically similar
SOLSTICE Trial Results Sponsored by AstraZeneca, the SOLSTICE trial enrolled 406 adults with type 2 diabetes across nine countries, including the United States
Body-mass index and all-cause mortality: an individual-participant-data meta-analysis of 239 prospective studies in four continents
At that point, weight stabilises
For many women with lipoedema, a personalised keto or low-carb protocol is sufficient to achieve meaningful metabolic improvement without pharmaceutical intervention
Its development demonstrates how peptide modification can improve upon natural hormones, providing longer duration of action and improved clinical utility